Reminders and small rewards to help people with HIV take their HIV pills regularly
INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)
This project uses daily reminders and small rewards to help people living with HIV take their antiretroviral pills regularly.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rand Corporation NIH-funded |
| Lab location | 1 site (Santa Monica, United States) |
| Project ID | NIH-11171473 on NIH RePORTER |
What this research studies
If you join, you'll be asked to pick an existing daily habit (an "anchor")—like breakfast or brushing your teeth—to pair with taking your HIV pill so it becomes automatic. Some participants will get daily reminder messages for three months to help stick to their anchoring plan, while another group will receive the same messages plus small monthly prizes when they take pills around their chosen routine. The team will monitor medication-taking using self-reports, electronic measures, and clinic lab results such as viral load. This larger project builds on a successful pilot and aims to create lasting pill-taking routines for more people.
Who could benefit from this research
Good fit: Ideal candidates are adults living with HIV who are prescribed antiretroviral therapy and want help forming a reliable pill-taking routine or who sometimes miss doses.
Not a fit: People who are already consistently adherent to every dose or who cannot receive daily messages or accept small incentives (due to phone access, privacy concerns, or preference) are less likely to benefit.
Why it matters
Potential benefit: If successful, the approach could help more people with HIV keep taking their ART on schedule and raise rates of viral suppression.
How similar studies have performed: A prior pilot (R34) from this team showed promising results using reminders and small incentives to form pill-taking routines, though larger confirmatory testing is still needed.
Where this research is happening
Santa Monica, United States
- Rand Corporation — Santa Monica, United States (Active)
Researchers
- Principal investigator: Linnemayr, Sebastian — Rand Corporation
- Study coordinator: Linnemayr, Sebastian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.